Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Squamous Cell × Imatinib Mesylate × 90 days × Clear all

Sponsor

Conditions

Gastrointestinal Stromal Tumors 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Burkitt Lymphoma 2 Uveal Melanoma 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Neoplasms 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Melanoma 1 Lymphangioleiomyomatosis 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Hypereosinophilic Syndrome 1 Digestive System Neoplasms 1 Desmoid Tumors 1 Dermatofibrosarcoma 1 Congenital Bone Marrow Failure Syndromes 1 Chordoma 1 Carcinoma, Adenoid Cystic 1 Blast Crisis 1

Interventions

Nivolumab 2 pembrolizumab 1 Taxes 1 Radiotherapy 1 Radiation 1 Paclitaxel 1 Injections 1 Erlotinib Hydrochloride 1 Docetaxel 1 Cisplatin 1 Cetuximab 1 Carboplatin 1 Biological Products 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡